MUKKA NSE filing

Mukka Proteins Receives GST Notice Demanding ₹141.06 Crore

The RealCase readMedium impact Negative

Why it matters

While the company believes the demand is not maintainable, the amount is substantial and could potentially impact the company's financials if the appeal is not successful.

The market read

The announcement discusses a significant GST demand of ₹141.06 crore, which is inherently negative.

* Mukka Proteins Limited received a GST notice from the State Tax Officer, Porbandar (Gujarat) on 17 September 2025. * The notice pertains to FY 2021-22 and cites discrepancies in turnover reporting, short payment of GST, differences in reconciliation between GSTR-1, GSTR-3B, and GSTR-9, excess input tax credit availed, ineligible ITC under Section 17(5), and late filing of GSTR-1. * The total demand proposed, including SGST, CGST, IGST, Cess, interest, penalty, and late fees, aggregates to approximately ₹141.06 crore. * The company is examining the matter and will take appropriate action. * The tax demand for the FY 2021-22 includes: * Total Tax Liability – ₹77.77 crore * Interest – ₹55.50 crore * Penalty – ₹7.77 crore * Late Fee – ₹1,200 * The Company believes the demand is not maintainable and is evaluating options, including filing an appeal. They do not anticipate any relevant impact on financials, operations, or other activities.

Filing to action

What to do with a filing like this

Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under legal. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.

View original filing